AAAAAA

   
Results: 1-7 |
Results: 7
INCREASED SENSITIVITY OF FACTOR-IX TO PHENPROCOUMON AS A CAUSE OF BLEEDING IN A PATIENT WITH ANTIPHOSPHOLIPID ANTIBODY ASSOCIATED THROMBOSIS
Authors: HARBRECHT U OLDENBURG J KLEIN P WEBER D ROCKSTROH J HANFLAND P
Citation: U. Harbrecht et al., INCREASED SENSITIVITY OF FACTOR-IX TO PHENPROCOUMON AS A CAUSE OF BLEEDING IN A PATIENT WITH ANTIPHOSPHOLIPID ANTIBODY ASSOCIATED THROMBOSIS, Journal of internal medicine, 243(1), 1998, pp. 73-77
EFFECT OF HYDROCORTISONE ON THE ACCUMULATION OF LDL AND FIBRINOGEN BYARTERIAL-WALLS AND OTHER TISSUES OF THE RAT
Authors: CARDONASANCLEMENTE LE HARBRECHT U MEDINA R FARMER H BORN GVR
Citation: Le. Cardonasanclemente et al., EFFECT OF HYDROCORTISONE ON THE ACCUMULATION OF LDL AND FIBRINOGEN BYARTERIAL-WALLS AND OTHER TISSUES OF THE RAT, Journal of physiology, 511P, 1998, pp. 114-114
MISSENSE MUTATIONS AT ALA-10 IN THE FACTOR IX-PROPEPTIDE - A NOVEL MECHANISM FOR SEVERE BLEEDING DURING ORAL ANTICOAGULANT-THERAPY
Authors: OLDENBURG J QUENZEL M HARBRECHT U FREGIN A KRESS W GRIMM T HERTFELDER HJ SCHWAAB R BRACKMANN HH HANFLAND P
Citation: J. Oldenburg et al., MISSENSE MUTATIONS AT ALA-10 IN THE FACTOR IX-PROPEPTIDE - A NOVEL MECHANISM FOR SEVERE BLEEDING DURING ORAL ANTICOAGULANT-THERAPY, Thrombosis and haemostasis, 1997, pp. 720-720
APC RESISTANCE IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II
Authors: HARBRECHT U UNKRIG C WEBER D HERTFELDER HJ HANFLAND P
Citation: U. Harbrecht et al., APC RESISTANCE IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II, Thrombosis and haemostasis, 1997, pp. 1310-1310
IMPROVED GLOBAL FIBRINOLYTIC-ACTIVITY DETERMINATION IN BLOOD-SAMPLES ANTICOAGULATED WITH STABILYTE(TM) SOLUTION
Authors: HERTFELDER HJ HARBRECHT U QUADE A QUENZEL EM HANFLAND P
Citation: Hj. Hertfelder et al., IMPROVED GLOBAL FIBRINOLYTIC-ACTIVITY DETERMINATION IN BLOOD-SAMPLES ANTICOAGULATED WITH STABILYTE(TM) SOLUTION, Thrombosis and haemostasis, 1997, pp. 2292-2292
SHOULD PATIENTS STARTING ANTICOAGULANT-THERAPY BE SCREENED FOR MISSENSE MUTATIONS AT ALA-10 IN THE FACTOR-IX PROPEPTIDE
Authors: OLDENBURG J HARBRECHT U
Citation: J. Oldenburg et U. Harbrecht, SHOULD PATIENTS STARTING ANTICOAGULANT-THERAPY BE SCREENED FOR MISSENSE MUTATIONS AT ALA-10 IN THE FACTOR-IX PROPEPTIDE, British Journal of Haematology, 99(2), 1997, pp. 468-468
MISSENSE MUTATIONS AT ALA-10 IN THE FACTOR-IX PROPEPTIDE - AN INSIGNIFICANT VARIANT IN NORMAL LIFE BUT A DECISIVE CAUSE OF BLEEDING DURING ORAL ANTICOAGULANT-THERAPY
Authors: OLDENBURG J QUENZEL EM HARBRECHT U FREGIN A KRESS W MULLER CR HERTFELDER HJ SCHWAAB R BRACKMANN HH HANFLAND P
Citation: J. Oldenburg et al., MISSENSE MUTATIONS AT ALA-10 IN THE FACTOR-IX PROPEPTIDE - AN INSIGNIFICANT VARIANT IN NORMAL LIFE BUT A DECISIVE CAUSE OF BLEEDING DURING ORAL ANTICOAGULANT-THERAPY, British Journal of Haematology, 98(1), 1997, pp. 240-244
Risultati: 1-7 |